Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study.

José Medina-PestanaCinthia Montenegro TeixeiraLaila Almeida VianaSilvia Regina ManfrediMonica Rika NakamuraElizabeth França LucenaAdriano Luiz AmirattiHelio Tedesco-SilvaDimas Tadeu CovasMarina Pontello Cristelli

Published in: Clinical kidney journal (2021)

Keyphrases

chronic kidney disease
end stage renal disease
open label
peritoneal dialysis
double blind
placebo controlled
clinical trial